{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:31:18Z","timestamp":1792647078708,"version":"4.5.0"},"reference-count":117,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:00:00Z","timestamp":1599004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["T996-B30"],"award-info":[{"award-number":["T996-B30"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Neurosci."],"DOI":"10.3389\/fnmol.2020.00159","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T03:19:41Z","timestamp":1599016781000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":51,"title":["Myasthenia Gravis With Antibodies Against Muscle Specific Kinase: An Update on Clinical Features, Pathophysiology and Treatment"],"prefix":"10.3389","volume":"13","author":[{"given":"Michelangelo","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Koneczny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.humimm.2013.08.271","article-title":"Association of HLA-DRB1*14, -DRB1*16 and -DQB1*05 with MuSK-myasthenia gravis in patients from Turkey","volume":"74","author":"Alahgholi-Hajibehzad","year":"2013","journal-title":"Hum. Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"jcs215251","DOI":"10.1242\/jcs.215251","article-title":"Balanced Rac1 activity controls formation and maintenance of neuromuscular acetylcholine receptor clusters","volume":"131","author":"Bai","year":"2018","journal-title":"J. Cell Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1212\/01.wnl.0000339103.08830.86","article-title":"HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5","volume":"72","author":"Bartoccioni","year":"2009","journal-title":"Neurology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jneuroim.2005.08.016","article-title":"MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo","volume":"170","author":"Benveniste","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.molcel.2010.06.007","article-title":"The cytoplasmic adaptor protein Dok7 activates the receptor tyrosine kinase MuSK via dimerization","volume":"39","author":"Bergamin","year":"2010","journal-title":"Mol. Cell"},{"key":"B6","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/1531-8249(200004)47:4<504::aid-ana14>3.0.co;2-q","article-title":"IgG from \u201cseronegative\u201d myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor","volume":"47","author":"Blaes","year":"2000","journal-title":"Ann. Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1083\/jcb.153.1.1","article-title":"Agrin-induced phosphorylation of the acetylcholine receptor regulates cytoskeletal anchoring and clustering","volume":"153","author":"Borges","year":"2001","journal-title":"J. Cell Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e34375","DOI":"10.7554\/eLife.34375","article-title":"Preserving neuromuscular synapses in ALS by stimulating MuSK with a therapeutic agonist antibody","volume":"7","author":"Cantor","year":"2018","journal-title":"eLife"},{"key":"B9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in Myasthenia Gravis","volume":"10","author":"Carr","year":"2010","journal-title":"BMC Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","article-title":"Rituximab for IgG4-related disease: a prospective, open-label trial","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1083\/jcb.200307164","article-title":"MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction","volume":"165","author":"Cartaud","year":"2004","journal-title":"J. Cell Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1073\/pnas.67.3.1241","article-title":"Use of a snake venom toxin to characterize the cholinergic receptor protein","volume":"67","author":"Changeux","year":"1970","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.neuron.2007.06.031","article-title":"Rapsyn interaction with calpain stabilizes AChR clusters at the neuromuscular junction","volume":"55","author":"Chen","year":"2007","journal-title":"Neuron"},{"key":"B14","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/mus.26404","article-title":"Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis","volume":"59","author":"Clifford","year":"2019","journal-title":"Muscle Nerve"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1113\/jphysiol.2010.190298","article-title":"Patient autoantibodies deplete postsynaptic muscle-specific kinase leading to disassembly of the ACh receptor scaffold and myasthenia gravis in mice","volume":"588","author":"Cole","year":"2010","journal-title":"J. Physiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/s0092-8674(00)81251-9","article-title":"The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo","volume":"85","author":"DeChiara","year":"1996","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1212\/01.wnl.0000254620.45529.97","article-title":"Clinical comparison of anti-MuSK- vs. anti-AChR-positive and seronegative myasthenia gravis","volume":"68","author":"Deymeer","year":"2007","journal-title":"Neurology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1136\/jnnp-2019-322606","article-title":"Rituximab in AChR subtype of myasthenia gravis: systematic review","volume":"91","author":"Di Stefano","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1212\/WNL.0b013e3182407982","article-title":"Long-lasting treatment effect of rituximab in MuSK myasthenia","volume":"78","author":"D\u00edaz-Manera","year":"2012","journal-title":"Neurology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1600-0404.2006.00606.x","article-title":"Clinical aspects of neuromuscular transmission disorders","volume":"183","author":"Evoli","year":"2006","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"B22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1749-6632.2012.06781.x","article-title":"Management challenges in muscle-specific tyrosine kinase myasthenia gravis","volume":"1274","author":"Evoli","year":"2012","journal-title":"Ann. N Y Acad. Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1212\/wnl.0000000000002466","article-title":"3,4-Diaminopyridine may improve myasthenia gravis with MuSK antibodies","volume":"86","author":"Evoli","year":"2016","journal-title":"Neurology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1212\/WNL.0000000000002466","article-title":"Pattern of ocular involvement in myasthenia gravis with MuSK antibodies","volume":"88","author":"Evoli","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1196\/annals.1405.012","article-title":"Response to therapy in myasthenia gravis with anti-MuSK antibodies","volume":"1132","author":"Evoli","year":"2008","journal-title":"Ann. N Y Acad. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"key":"B27","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/mus.20491","article-title":"Single-fiber electromyography in limb and facial muscles in muscle-specific kinase antibody and acetylcholine receptor antibody myasthenia gravis","volume":"33","author":"Farrugia","year":"","journal-title":"Muscle Nerve"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1093\/brain\/awl095","article-title":"MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis","volume":"129","author":"Farrugia","year":"","journal-title":"Brain"},{"key":"B29","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nn1071","article-title":"Postsynaptic requirement for Abl kinases in assembly of the neuromuscular junction","volume":"6","author":"Finn","year":"2003","journal-title":"Nat. Neurosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"4471","DOI":"10.1242\/dev.02044","article-title":"Neuromuscular synapses can form in vivo by incorporation of initially aneural postsynaptic specializations","volume":"132","author":"Flanagan-Steet","year":"2005","journal-title":"Development."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.2169\/internalmedicine.54.4645","article-title":"Anti-MuSK antibody-positive myasthenia gravis mimicking amyotrophic lateral sclerosis","volume":"54","author":"Furuta","year":"2015","journal-title":"Intern Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/s0009-2797(99)00040-x","article-title":"Acetylcholinesterase in the neuromuscular junction","author":"Ga\u0161per\u0161i\u010d","year":"1999","journal-title":"Chem. Biol. Interact."},{"key":"B33","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/s0092-8674(00)81252-0","article-title":"Agrin acts via a MuSK receptor complex","volume":"85","author":"Glass","year":"","journal-title":"Cell"},{"key":"B34","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1101\/SQB.1996.061.01.046","article-title":"The receptor tyrosine kinase MuSK is required for neuromuscular junction formation and is a functional receptor for agrin","volume":"61","author":"Glass","year":"","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1083\/jcb.99.2.615","article-title":"Components of Torpedo electric organ and muscle that cause aggregation of acetylcholine receptors on cultured muscle cells","volume":"99","author":"Godfrey","year":"1984","journal-title":"J. Cell Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/WCO.0b013e32833c0982","article-title":"Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis","volume":"23","author":"Guptill","year":"2010","journal-title":"Curr. Opin. Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/mus.22006","article-title":"Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts","volume":"44","author":"Guptill","year":"2011","journal-title":"Muscle Nerve"},{"key":"B38","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/mus.20479","article-title":"Successful treatment of MuSK antibody-positive myasthenia gravis with rituximab","volume":"33","author":"Hain","year":"2006","journal-title":"Muscle Nerve"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1101\/gad.1977710","article-title":"Dok-7 regulates neuromuscular synapse formation by recruiting Crk and Crk-L","volume":"24","author":"Hallock","year":"2010","journal-title":"Genes Dev."},{"key":"B40","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.clineuro.2012.06.038","article-title":"Can a rare form of myasthenia gravis shed additional light on disease mechanisms?","volume":"115","author":"Haran","year":"2013","journal-title":"Clin. Neurol. Neurosurg."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1212\/WNL.0000000000004341","article-title":"Rituximab as treatment for anti-MuSK myasthenia gravis: multicenter blinded prospective review","volume":"89","author":"Hehir","year":"2017","journal-title":"Neurology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e645","DOI":"10.1212\/nxi.0000000000000645","article-title":"SHP2 inhibitor protects AChRs from effects of myasthenia gravis MuSK antibody","volume":"7","author":"Huda","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e357","DOI":"10.1212\/nxi.0000000000000357","article-title":"IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MG","volume":"4","author":"Huda","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"B45","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.nmd.2016.04.004","article-title":"Myasthenia gravis with muscle specific kinase antibodies mimicking amyotrophic lateral sclerosis","volume":"26","author":"Huijbers","year":"2016","journal-title":"Neuromuscul. Disord."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e547","DOI":"10.1212\/nxi.0000000000000547","article-title":"MuSK myasthenia gravis monoclonal antibodies: valency dictates pathogenicity","volume":"6","author":"Huijbers","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"B47","doi-asserted-by":"publisher","first-page":"20783","DOI":"10.1073\/pnas.1313944110","article-title":"MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4","volume":"110","author":"Huijbers","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.3389\/fimmu.2019.01990","article-title":"Systematic review of safety and efficacy of rituximab in treating immune-mediated disorders","volume":"10","author":"Kaegi","year":"2019","journal-title":"Front. Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/82_2016_36","article-title":"Diagnosis and treatment of IgG4-related disease","volume":"401","author":"Kamisawa","year":"2017","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1212\/WNL.0b013e318237f660","article-title":"Anti-MuSK autoantibodies block binding of collagen Q to MuSK","volume":"77","author":"Kawakami","year":"2011","journal-title":"Neurology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1136\/jnnp-2012-303664","article-title":"Long-term benefit of rituximab in MuSK autoantibody myasthenia gravis patients","volume":"84","author":"Keung","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B52","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1073\/pnas.1524272113","article-title":"Sympathetic innervation controls homeostasis of neuromuscular junctions in health and disease","volume":"113","author":"Khan","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/art.27435","article-title":"Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease","volume":"62","author":"Khosroshahi","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1093\/brain\/aws025","article-title":"Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice","volume":"135","author":"Klooster","year":"2012","journal-title":"Brain"},{"key":"B55","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fimmu.2018.00097","article-title":"A new classification system for IgG4 autoantibodies","volume":"9","author":"Koneczny","year":"2018","journal-title":"Front. Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e80695","DOI":"10.1371\/journal.pone.0080695","article-title":"MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1\u20133 can disperse preformed agrin-independent AChR clusters","volume":"8","author":"Koneczny","year":"2013","journal-title":"PLoS One"},{"key":"B57","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jaut.2016.11.005","article-title":"IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients","volume":"77","author":"Koneczny","year":"2017","journal-title":"J. Autoimmun."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1002\/j.1460-2075.1991.tb08070.x","article-title":"Primary structure of a collagenic tail peptide of Torpedo acetylcholinesterase: co-expression with catalytic subunit induces the production of collagen-tailed forms in transfected cells","volume":"10","author":"Krejci","year":"1991","journal-title":"EMBO J."},{"key":"B59","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jneuroim.2016.04.003","article-title":"MuSK induced experimental autoimmune myasthenia gravis does not require IgG1 antibody to MuSK","author":"K\u00fc\u00e7\u00fckerden","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/1346-8138.14732","article-title":"Rituximab therapy for refractory autoimmune bullous diseases: a multicenter, open-label, single-arm, phase 1\/2 study on 10 Japanese patients","volume":"46","author":"Kurihara","year":"2019","journal-title":"J. Dermatol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/nyas.13538","article-title":"Therapeutic strategies for congenital myasthenic syndromes","volume":"1412","author":"Lee","year":"2018","journal-title":"Ann. N Y Acad. Sci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1523\/JNEUROSCI.6185-08.2009","article-title":"Binding to gating transduction in nicotinic receptors: Cys-loop energetically couples to pre-M1 and M2\u2013M3 regions","volume":"29","author":"Lee","year":"2009","journal-title":"J. Neurosci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1093\/brain\/awn092","article-title":"IgG1 antibodies to acetylcholine receptors in \u2018seronegative\u2019 myasthenia gravis","volume":"131","author":"Leite","year":"2008","journal-title":"Brain"},{"key":"B64","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.neuron.2005.04.002","article-title":"Neurotransmitter acetylcholine negatively regulates neuromuscular synapse formation by a Cdk5-dependent mechanism","volume":"46","author":"Lin","year":"2005","journal-title":"Neuron"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1212\/wnl.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1074\/mcp.m800563-mcp200","article-title":"Immunocapture and identification of cell membrane protein antigenic targets of serum autoantibodies","volume":"8","author":"Littleton","year":"2009","journal-title":"Mol. Cell. Proteomics"},{"key":"B67","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1136\/jnnp.2009.197632","article-title":"The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome","volume":"82","author":"Maddison","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B68","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","article-title":"The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes","volume":"12","author":"Marx","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"B69","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cccn.2004.05.008","article-title":"Muscle-specific receptor tyrosine kinase autoantibodies\u2014a new immunoprecipitation assay","volume":"348","author":"Matthews","year":"2004","journal-title":"Clin. Chim. Acta"},{"key":"B70","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/ana.20061","article-title":"Detection and characterization of MuSK antibodies in seronegative myasthenia gravis","volume":"55","author":"McConville","year":"2004","journal-title":"Ann. Neurol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1101\/sqb.1990.055.01.041","article-title":"The agrin hypothesis","volume":"55","author":"McMahan","year":"1990","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"14505","DOI":"10.1074\/jbc.m007024200","article-title":"Agrin-induced activation of acetylcholine receptor-bound Src family kinases requires Rapsyn and correlates with acetylcholine receptor clustering","volume":"276","author":"Mittaud","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B73","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.ajpath.2011.10.031","article-title":"Antibodies against muscle-specific kinase impair both presynaptic and postsynaptic functions in a murine model of myasthenia gravis","volume":"180","author":"Mori","year":"2012","journal-title":"Am. J. Pathol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1113\/jphysiol.2013.251827","article-title":"Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody","volume":"591","author":"Morsch","year":"2013","journal-title":"J. Physiol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/s0140-6736(86)92259-2","article-title":"Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity","volume":"1","author":"Mossman","year":"1986","journal-title":"Lancet"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1212\/01.wnl.0000218159.79769.5c","article-title":"Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5","volume":"66","author":"Niks","year":"2006","journal-title":"Neurology"},{"key":"B77","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1136\/jnnp.2006.102517","article-title":"Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in The Netherlands","volume":"78","author":"Niks","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B78","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/374258a0","article-title":"Aberrant differentiation of neuromuscular junctions in mice lacking s-laminin\/laminin \u03b2 2","volume":"374","author":"Noakes","year":"1995","journal-title":"Nature"},{"key":"B79","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1177\/1756285611411503","article-title":"Response of patients with refractory myasthenia gravis to rituximab: a retrospective study","volume":"4","author":"Nowak","year":"2011","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"B80","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/mus.21191","article-title":"Racial differences in myasthenia gravis in Alabama","volume":"39","author":"Oh","year":"2009","journal-title":"Muscle Nerve"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/j.1468-1331.2007.01870.x","article-title":"Clinical and experimental features of MuSK antibody positive MG in Japan","volume":"14","author":"Ohta","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"13928","DOI":"10.1038\/srep13928","article-title":"Collagen Q and anti-MuSK autoantibody competitively suppress agrin\/LRP4\/MuSK signaling","volume":"5","author":"Otsuka","year":"2015","journal-title":"Sci. Rep."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1083\/jcb.201810023","article-title":"MACF1 links Rapsyn to microtubule- and actin-binding proteins to maintain neuromuscular synapses","volume":"218","author":"Oury","year":"2019","journal-title":"J. Cell Biol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1002\/ajmg.a.38707","article-title":"Recessive variants of MuSK are associated with late onset CMS and predominant limb girdle weakness","volume":"176","author":"Owen","year":"2018","journal-title":"Am. J. Med. Genet. A"},{"key":"B85","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1523\/JNEUROSCI.3656-05.2006","article-title":"In vivo imaging of preferential motor axon outgrowth to and synaptogenesis at prepatterned acetylcholine receptor clusters in embryonic zebrafish skeletal muscle","volume":"26","author":"Panzer","year":"2006","journal-title":"J. Neurosci."},{"key":"B86","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/mus.21533","article-title":"Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience","volume":"41","author":"Pasnoor","year":"2010","journal-title":"Muscle Nerve"},{"key":"B87","doi-asserted-by":"publisher","first-page":"e110571","DOI":"10.1371\/journal.pone.0110571","article-title":"Altered active zones, vesicle pools, nerve terminal conductivity and morphology during experimental MuSK myasthenia gravis","volume":"9","author":"Patel","year":"2014","journal-title":"PLoS One"},{"key":"B88","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/88414","article-title":"Properly formed but improperly localized synaptic specializations in the absence of laminin \u03b14","volume":"4","author":"Patton","year":"2001","journal-title":"Nat. Neurosci."},{"key":"B89","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1471-2202-9-70","article-title":"The function of Shp2 tyrosine phosphatase in the dispersal of acetylcholine receptor clusters","volume":"9","author":"Qian","year":"2008","journal-title":"BMC Neurosci."},{"key":"B90","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/humu.23949","article-title":"Congenital myasthenic syndrome due to mutations in MUSK suggests that the level of MuSK phosphorylation is crucial for governing synaptic structure","volume":"41","author":"Rodr\u00edguez Cruz","year":"2020","journal-title":"Hum. Mutat."},{"key":"B91","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1046\/j.1525-1594.2001.06717.x","article-title":"Immunoglobulin treatment versus plasma exchange in patients with chronic moderate to severe myasthenia gravis","volume":"25","author":"R\u00f8nager","year":"2001","journal-title":"Artif. Organs"},{"key":"B92","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3109\/08916930903518107","article-title":"Immunosuppressive therapies in myasthenia gravis","volume":"43","author":"Sanders","year":"2010","journal-title":"Autoimmunity"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1097\/01.lab.0000028144.48023.9b","article-title":"Anti-p110 autoantibodies identify a subtype of \u201cseronegative\u201d myasthenia gravis with prominent oculobulbar involvement","volume":"82","author":"Scuderi","year":"2002","journal-title":"Lab. Invest."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1172\/JCI21545","article-title":"Induction of myasthenia by immunization against muscle-specific kinase","volume":"116","author":"Shigemoto","year":"2006","journal-title":"J. Clin. Invest."},{"key":"B95","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/mus.23907","article-title":"Muscle-specific kinase antibodies: a novel cause of peripheral nerve hyperexcitability?","volume":"48","author":"Simon","year":"2013","journal-title":"Muscle Nerve"},{"key":"B96","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.nmd.2013.07.010","article-title":"Muscle specific kinase autoimmune myasthenia gravis in children: a case series","volume":"23","author":"Skjei","year":"2013","journal-title":"Neuromuscul. Disord."},{"key":"B97","doi-asserted-by":"publisher","first-page":"e127167","DOI":"10.1172\/jci.insight.127167","article-title":"Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients","volume":"4","author":"Takata","year":"2019","journal-title":"JCI Insight"},{"key":"B98","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00415-019-09191-6","article-title":"High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria","volume":"266","author":"Topakian","year":"2019","journal-title":"J. Neurol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/j.1468-1331.2009.02624.x","article-title":"Epidemiological and immunological profile of muscle-specific kinase myasthenia gravis in Greece","volume":"16","author":"Tsiamalos","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1159\/000330031","article-title":"Increased complement consumption in MuSK-antibody-positive myasthenia gravis patients","volume":"20","author":"T\u00fcz\u00fcn","year":"2011","journal-title":"Med. Princ. Pract."},{"key":"B101","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/jca.21694","article-title":"Excellent response to therapeutic plasma exchange in myasthenia gravis patients irrespective of antibody status","volume":"34","author":"Usmani","year":"2019","journal-title":"J. Clin. Apher."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1126\/science.1144603","article-title":"Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange","volume":"317","author":"van der Neut Kolfschoten","year":"2007","journal-title":"Science"},{"key":"B103","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front. Immunol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.expneurol.2012.01.025","article-title":"Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects","volume":"234","author":"Viegas","year":"2012","journal-title":"Exp. Neurol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/s1474-4422(03)00306-5","article-title":"Seronegative generalised myasthenia gravis: clinical features, antibodies and their targets","volume":"2","author":"Vincent","year":"2003","journal-title":"Lancet Neurol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/01.wco.0000180660.57801.3f","article-title":"Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis","volume":"18","author":"Vincent","year":"2005","journal-title":"Curr. Opin. Neurol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1196\/annals.1405.020","article-title":"Myasthenia gravis seronegative for acetylcholine receptor antibodies","volume":"1132","author":"Vincent","year":"2008","journal-title":"Ann. N Y Acad. Sci."},{"key":"B108","first-page":"257","article-title":"Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles","volume":"49","author":"Vincent","year":"1982","journal-title":"Clin. Exp. Immunol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"6450","DOI":"10.1074\/jbc.m210249200","article-title":"Cooperative regulation by Rac and Rho of agrin-induced acetylcholine receptor clustering in muscle cells","volume":"278","author":"Weston","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B110","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuron.2012.04.033","article-title":"Distinct roles of muscle and motoneuron LRP4 in neuromuscular junction formation","volume":"75","author":"Wu","year":"2012","journal-title":"Neuron"},{"key":"B111","doi-asserted-by":"publisher","first-page":"e49180","DOI":"10.7554\/elife.49180","article-title":"A mechanism in agrin signaling revealed by a prevalent Rapsyn mutation in congenital myasthenic syndrome","volume":"8","author":"Xing","year":"2019","journal-title":"eLife"},{"key":"B112","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.neuroscience.2006.09.022","article-title":"Delayed synapsing muscles are more severely affected in an experimental model of MuSK-induced myasthenia gravis","volume":"143","author":"Xu","year":"2006","journal-title":"Neuroscience"},{"key":"B113","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nature11348","article-title":"Lrp4 is a retrograde signal for presynaptic differentiation at neuromuscular synapses","volume":"489","author":"Yumoto","year":"2012","journal-title":"Nature"},{"key":"B115","doi-asserted-by":"publisher","first-page":"40624","DOI":"10.1074\/jbc.M111.279307","article-title":"Agrin binds to the N-terminal region of Lrp4 protein and stimulates association between Lrp4 and the first immunoglobulin-like domain in muscle-specific kinase (MuSK)","volume":"286","author":"Zhang","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B114","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.neuron.2008.10.006","article-title":"LRP4 serves as a coreceptor of agrin","volume":"60","author":"Zhang","year":"2008","journal-title":"Neuron"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1002\/dneu.20556","article-title":"Regulation of ACh receptor clustering by the tyrosine phosphatase Shp2","volume":"67","author":"Zhao","year":"2007","journal-title":"Dev. Neurobiol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1101\/gad.180885.111","article-title":"Structural basis of agrin-LRP4-MuSK signaling","volume":"26","author":"Zong","year":"2012","journal-title":"Genes Dev."},{"key":"B118","doi-asserted-by":"publisher","first-page":"10622","DOI":"10.1073\/pnas.1301277110","article-title":"Structure and superorganization of acetylcholine receptor-rapsyn complexes","volume":"110","author":"Zuber","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A"}],"container-title":["Frontiers in Molecular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnmol.2020.00159\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T03:19:45Z","timestamp":1599016785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnmol.2020.00159\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,2]]},"references-count":117,"alternative-id":["10.3389\/fnmol.2020.00159"],"URL":"https:\/\/doi.org\/10.3389\/fnmol.2020.00159","relation":{},"ISSN":["1662-5099"],"issn-type":[{"value":"1662-5099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,2]]},"article-number":"159"}}